About China Pharma (NYSEAMERICAN:CPHI)
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
Industry, Sector and Symbol
Industry Drug Manufacturers - Major
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity-15.43%
Return on Assets-11.58%
China Pharma (NYSEAMERICAN:CPHI) Frequently Asked Questions
What is China Pharma's stock symbol?
China Pharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CPHI."
How were China Pharma's earnings last quarter?
China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) issued its earnings results on Wednesday, November, 15th. The company reported ($0.05) earnings per share for the quarter. The company earned $3.16 million during the quarter. China Pharma had a negative return on equity of 15.43% and a negative net margin of 69.43%. During the same period last year, the firm earned ($0.04) earnings per share. View China Pharma's Earnings History.
Are investors shorting China Pharma?
China Pharma saw a drop in short interest in the month of March. As of March 15th, there was short interest totalling 50,013 shares, a drop of 63.7% from the February 28th total of 137,864 shares. Based on an average daily trading volume, of 495,014 shares, the short-interest ratio is presently 0.1 days. Approximately 0.2% of the company's stock are short sold.
Who are some of China Pharma's key competitors?
Some companies that are related to China Pharma include GlaxoSmithKline (GSK), Beximco Pharmaceuticals (BXP), Otsuka (OTSKY), Mayne Pharma Group (MYX), Vectura Group (VEC), Trilogy International Partners (TRL), Sinclair Pharma (SPH), Pharmaxis (PXS), NanoViricides (NNVC), Futura Medical (FUM), Sareum (SAR) and Ultima (N4P).
Who are China Pharma's key executives?
China Pharma's management team includes the folowing people:
- Ms. Zhilin Li, Chairman, Pres, CEO & Interim CFO (Age 65)
- Ms. Yao Huang, Chief Technical Officer
- Ms. Jian Yang, Sec. (Age 58)
Has China Pharma been receiving favorable news coverage?
News coverage about CPHI stock has trended positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. China Pharma earned a coverage optimism score of 0.42 on Accern's scale. They also gave press coverage about the company an impact score of 43.95 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of China Pharma?
Shares of CPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is China Pharma's stock price today?
One share of CPHI stock can currently be purchased for approximately $0.30.
How big of a company is China Pharma?
China Pharma has a market capitalization of $14.73 million.
How can I contact China Pharma?
China Pharma's mailing address is 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China. The company can be reached via phone at +86-898-66811730.
MarketBeat Community Rating for China Pharma (CPHI)MarketBeat's community ratings are surveys of what our community members think about China Pharma and other stocks. Vote "Outperform" if you believe CPHI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPHI will underperform the S&P 500 over the long term. You may vote once every thirty days.
China Pharma (NYSEAMERICAN:CPHI) Analyst Ratings History
(Data available from 4/25/2016 forward)
China Pharma (NYSEAMERICAN:CPHI) Earnings History and Estimates Chart
China Pharma (NYSEAMERICAN CPHI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/15/2017||Q3 17||($0.05)||$3.16 million||View||N/A|
|8/15/2017||Q2 2017||($0.05)||$2.92 million||View||N/A|
|5/12/2017||Q1 17||($0.02)||$3.29 million||View||N/A|
|3/31/2017||Q4 2016||($0.08)||$5.26 million||View||N/A|
|11/15/2016||Q316||($0.04)||$26.78 million||$3.10 million||View||N/A|
|8/11/2016||Q216||($0.06)||$26.78 million||$3.50 million||View||N/A|
|5/17/2016||Q116||($0.04)||$26.78 million||$3.60 million||View||N/A|
|3/31/2016||Q4 2015||$0.02||$4.50 million||View||N/A|
|11/17/2015||Q315||($0.10)||$26.78 million||$4.80 million||View||N/A|
|8/14/2015||Q215||($0.09)||$26.78 million||$5.70 million||View||N/A|
|5/12/2015||Q115||($0.18)||$26.78 million||$5.70 million||View||N/A|
|3/31/2015||Q4 2014||($0.20)||$6.13 million||View||N/A|
|11/14/2014||Q3 2014||($0.15)||$5.57 million||View||N/A|
|8/15/2014||Q2 14||($0.20)||$8.00 million||$6.10 million||View||N/A|
|5/15/2014||Q114||($0.05)||$8.20 million||$7.10 million||View||N/A|
|3/21/2014||Q4 2013||($0.24)||$8.41 million||View||N/A|
|11/15/2013||Q313||($0.05)||$12.20 million||$8.10 million||View||N/A|
|8/14/2013||Q2 2013||($0.10)||$8.03 million||View||N/A|
|5/15/2013||Q1 2013||($0.06)||$8.25 million||View||Listen|
China Pharma (NYSEAMERICAN:CPHI) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
China Pharma (NYSEAMERICAN CPHI) Insider Trading and Institutional Ownership History
China Pharma (NYSEAMERICAN CPHI) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
China Pharma (NYSEAMERICAN CPHI) News Headlines
|Blog Exposure - Tonix Pharma Announces 50% Enrolment in Tonmya® Study for PTSD|
finance.yahoo.com - April 5 at 8:27 AM
|China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results|
finance.yahoo.com - April 3 at 10:20 AM
|China Pharma Holdings, Inc. (CPHI) Sees Large Decline in Short Interest|
www.americanbankingnews.com - March 27 at 1:02 AM
|CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET|
finance.yahoo.com - March 22 at 10:12 AM
|China Pharma (CPHI) Scheduled to Post Quarterly Earnings on Thursday|
www.americanbankingnews.com - March 22 at 1:14 AM
|GNC Holdings Expands in India, Boosts International Business|
www.msn.com - March 12 at 4:59 PM
|China Pharma Holdings, Inc. (CPHI) Sees Large Increase in Short Interest|
www.americanbankingnews.com - March 9 at 6:23 PM
|Short Interest in China Pharma Holdings, Inc. (CPHI) Drops By 95.0%|
www.americanbankingnews.com - February 28 at 1:08 AM
|GNC's stock rockets after big investment from China's Harbin Pharmaceutical|
www.marketwatch.com - February 13 at 8:47 AM
|China Pharma Holdings, Inc. (CPHI) Short Interest Up 71.6% in December|
www.americanbankingnews.com - December 27 at 7:24 PM
|Walgreens Boots Alliance (WBA) Enters Pact to Reduce Stake in Guangzhou Pharmaceuticals Corporation|
www.streetinsider.com - December 22 at 9:19 AM
|China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017|
finance.yahoo.com - December 1 at 4:32 PM
|China, Hong Kong stocks fall on caution after N.Korea missile test|
www.reuters.com - November 29 at 9:10 AM
|China Pharma Holdings, Inc. (CPHI) Short Interest Update|
www.americanbankingnews.com - November 27 at 9:56 PM
|Conavi Medical and China Grand Pharmaceutical and Healthcare Enter into Distribution Agreement for Minimally Invasive Imaging Technologies in China|
www.businesswire.com - November 16 at 6:07 PM
|EARNINGS SUMMARY: Details of China Pharma Holdings Inc. Q3 Earnings Report|
www.rttnews.com - November 16 at 6:07 PM
|China Pharma Holdings' (CPHI) CEO Zhilin Li on Q3 2017 Results - Earnings Call Transcript|
seekingalpha.com - November 16 at 6:07 PM
|China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results|
finance.yahoo.com - November 16 at 1:03 PM
|China Pharma Holdings, Inc. (CPHI) Announces Quarterly Earnings Results|
www.americanbankingnews.com - November 16 at 9:44 AM
|Temasek Holdings (private) Ltd Buys Visa Inc, Virtu Financial Inc, Ctrip. ...|
www.nasdaq.com - November 15 at 4:51 AM
China Pharma (NYSEAMERICAN:CPHI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
China Pharma (NYSEAMERICAN CPHI) Stock Chart for Wednesday, April, 25, 2018